Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04500665 · ClinicalTrials.gov registry record · Phase 2
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
A Phase 2 study of Chronic Kidney Diseases, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04500665 is a Phase 2 study of Chronic Kidney Diseases that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04500665, a Phase 2 study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Colchicine
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-11-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04500665
The ClinicalTrials.gov registry entry for NCT04500665 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (96% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04500665 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04500665 about?
NCT04500665 is a clinical study titled "Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine". This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.
What is the current status of trial NCT04500665?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2021-11-01. Estimated completion is 2026-11-11.
What conditions does trial NCT04500665 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT04500665?
The interventions under investigation include: Placebo (DRUG), Colchicine (DRUG).
Who is sponsoring clinical trial NCT04500665?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04500665 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Ferric Citrate and Chronic Kidney Disease in Children
RECRUITING · Phase 2
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
RECRUITING · Phase 2
-
Combination of Novel Therapies for CKD Comorbid Depression
RECRUITING · Phase 2
-
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
RECRUITING · Phase 2
-
Sit Less, Interact and Move More (SLIMM) 2 Study
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.